Abderrahman Day

5PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 12, 2024
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts.

Zoi E Sychev, Abderrahman Day, Hannah E Bergom

|Jul 19, 2023
Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma.

Frank Cichocki, Bin Zhang, Cheng-Ying Wu

|May 01, 2023
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.

Justin Hwang, Xiaolei Shi, Andrew Elliott

|Apr 14, 2023
ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystems.

Hannah E Bergom, Ashraf Shabaneh, Abderrahman Day

|Nov 03, 2022
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer.

Xiaolei Shi, Abderrahman Day, Hannah E Bergom

Pageof 1